Skip to content

Personalized Support Using Instant Messaging Applications to Increase Smoking Cessation

Personalized Support Using Instant Messaging Applications to Increase Smoking Cessation in Smokers Proactively Recruited From Smoking Hotspots in Hong Kong: a Pragmatic Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03800719
Enrollment
696
Registered
2019-01-11
Start date
2018-12-15
Completion date
2020-12-31
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

smoking cessation, active referral, IM

Brief summary

This study aims to assess the effect of personalized support using instant messaging application on smoking cessation in smokers proactively recruited from smoking hotspots in Hong Kong.

Detailed description

Detailed Description: With the advancement of information communication technologies (ICTs), instant messaging applications (IM Apps, e.g. WhatsApp and WeChat) can be used for providing synchronous, personalized, interactive interventions for health promotion. This study proposes to apply IM Apps for enhancing our tested brief smoking cessation (SC) intervention model from AWARD to e-AWARD (AWARD: Ask, Warn, Advise, Refer, Do-it-again,) without medications to increase SC in smokers proactively recruited in smoking hotspots in Hong Kong. Such smokers are the majority and have low quit rate. IM Apps allows trained SC advisors to proactively deliver personalized SC advices, response to smokers' needs promptly, and provide psychosocial support. No similar trials are found in PubMed, Cochrane Library and trial registries (ClinicalTrials.gov & ISRCTN) (except the pilot trial of this study). The aims of this study are as follows: 1. To assess the main effect of the personalized support using instant messaging applications (Intervention) vs. Control group on biochemical validated smoking abstinence at 6-month and 12-month. 2. To assess the effects on self-reported past 7-day abstinence, 24-week continuous abstinence, smoking reduction, self-efficacy of quitting, intention to quit, quit attempts and SC medications and services use at 6-month and 12-month. 3. To identify the mediators, which can inform mechanisms of the intervention on SC. 4. To evaluate the cost-effectiveness of the above interventions. 5. To understand the effects subjects' experience of IM support on SC using a qualitative study approach.

Interventions

BEHAVIORALAWARD advice

At baseline, brief smoking cessation advice following AWARD model will be delivered to subjects within about 2 to 5 minutes: * Ask about smoking history and habit * Warn about the risks of smoking using a leaflet * Advise to quit smoking as soon as possible and use nicotine replacement therapy (NRT) or SC services * Refer subjects to free smoking cessation services in Hong Kong if they agree * Do it again: smokers who have tried to quit but relapsed will be encouraged to quit again and those who have reduced smoking will be advised to further reduce or quit smoking

BEHAVIORALMessage on general health delivered by short message service (SMS)

After baseline, regular messages using SMS will be sent to subjects with similar frequency to Intervention group. The messages include information on general health and reminders on follow-up surveys and biochemical validation for quitting.

At baseline, an A5-sized leaflet will be given to subjects, which includes information about risks of smoking, pictures of smoking-related diseases, and smoking cessation services provided in Hong Kong.

BEHAVIORALActive referral to smoking cessation (SC) services

At baseline, subjects will be encouraged to seek smoking cessation services in Hong Kong. If subjects agree, their contact information will be sent to the preferred service providers for a quick appointment and follow-up.

A total of pre-set 26 messages will be sent to subjects through WhatsApp 12 weeks after baseline to remind the quit date and to encourage abstinence. Messages are tailored based on subjects' sociodemographic characteristics and smoking habit following Social Cognitive Theory and Transtheoretical Model. Messages will be sent with the schedule of once daily for 1 week (the week across the quit date), 3 times a week for 4 weeks (2 weeks each before and after the week with quit date) and once a week for remaining 7 weeks. The schedule will be adjusted according to the quit date and also smokers' requests. The format of regular messages will mainly be text-based but also include pictures, animations and videos.

BEHAVIORALPsychosocial support and referral to SC services through IM

Personalized interactive text or voice conversation will be provided by trained smoking cessation advisors through WhatsApp for 3 months after baseline. Advisors will periodically proactively send messages to subjects to initiate the conversation (e.g. asking recent progress of smoking cessation) and deliver evidence-based advice. Advisors will also actively refer subjects, if they have expressed the need, to smoking cessation services providers. A standard operation algorithm for advisors used in the pilot feasibility trial will be modified for the use.

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult smokers aged 18+ who smoke cigarette(s) daily. * Exhaled carbon monoxide (CO) level of 4ppm or above. * Having smartphones with IM Apps (WhatsApp) and have experience in using. * Hong Kong residents able to read and communicate in Chinese (Cantonese or Putonghua).

Exclusion criteria

* Smokers who have psychiatric/psychological diseases or are on regular psychotropic medications. * Smokers who are using SC medication, NRT, other SC services or projects.

Design outcomes

Primary

MeasureTime frameDescription
Biochemically-validated abstinence at 6-month6-month after baselineDefined as exhaled carbon monoxide \<4ppm
Biochemically-validated abstinence at 12-month12-month after baselineDefined as exhaled carbon monoxide \<4ppm

Secondary

MeasureTime frameDescription
Smoking reduction6-month and 12-month after baselineSelf-reported reduction in the number of cigarettes smoked daily by at least 50% of the baseline amount
Perceived importance, confidence and difficulties of quitting6-month and 12-month after baselinePerceived importance, confidence and difficulties of quitting measured on a scale of 0-10 and a higher score indicates a stronger perception
Intention to quit6-month and 12-month after baselineAny intention to quit smoking (yes/no) from baseline
Self-reported past 7-day abstinence6-month and 12-month after baselineSelf-reported no cigarette smoking (even a single puff) in the past 7 days
Smoking cessation medication use6-month and 12-month after baselineAny use of nicotine replacement therapy from baseline
Smocking cessation services use6-month and 12-month after baselineAny use of counselling, hotline, SC clinics and other SC services from baseline
Quit attempts6-month and 12-month after baselineNumber of quit attempts from baseline
Self-reported 24-week continuous abstinence6-month and 12-month after baselineSelf-reported no cigarette smoking (even a single puff) in the past 24 weeks

Countries

Hong Kong

Contacts

Primary ContactFleur Lee, MPhil
fleurlee@hku.hk+852-39176955

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026